296 related articles for article (PubMed ID: 25239413)
1. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions.
San José ME; Ferreiro L; Soneira ME; González-Barcala FJ; Vázquez MC; Golpe A; Valdés L
Am J Clin Pathol; 2014 Oct; 142(4):467-73. PubMed ID: 25239413
[TBL] [Abstract][Full Text] [Related]
2. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-8 in differentiation of uncomplicated from complicated parapneumonic effusion.
Petrusevska Marinkovic S; Kondova Topuzovska I; Milenkovic Z; Kondov G; Bosevska G; Anastasovska A
Prilozi; 2011; 32(1):101-11. PubMed ID: 21822181
[TBL] [Abstract][Full Text] [Related]
4. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
Porcel JM; Vives M; Esquerda A
Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
[TBL] [Abstract][Full Text] [Related]
6. Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema.
Yang CY; Kuo YH; Chen M; Wang CL; Shih LJ; Liu YC; Hsueh PC; Lai YH; Chu CM; Wu CC; Wu KA
Sci Rep; 2021 Jan; 11(1):1763. PubMed ID: 33469074
[TBL] [Abstract][Full Text] [Related]
7. Correlation between levels of tumour necrosis factor-alpha and levels of pH, glucose, and lactate dehydrogenase in parapneumonic effusions.
Odeh M; Sabo E; Srugo I; Oliven A
J Infect; 2005 Feb; 50(2):114-9. PubMed ID: 15667911
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
Manuel Porcel J; Vives M; Esquerda A; Ruiz A
Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
[TBL] [Abstract][Full Text] [Related]
9. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
Tsujimoto N; Saraya T; Light RW; Tsukahara Y; Koide T; Kurai D; Ishii H; Kimura H; Goto H; Takizawa H
PLoS One; 2015; 10(6):e0130141. PubMed ID: 26076488
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.
Corral-Gudino L; García-Zamalloa A; Prada-González C; Bielsa S; Alexis D; Taboada-Gómez J; Dos-Santos-Gallego PR; Alonso-Fernández MA; Porcel JM
Lung; 2016 Oct; 194(5):847-54. PubMed ID: 27401009
[TBL] [Abstract][Full Text] [Related]
11. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema.
Wu KA; Wu CC; Liu YC; Hsueh PC; Chin CY; Wang CL; Chu CM; Shih LJ; Yang CY
BMC Pulm Med; 2019 Jun; 19(1):108. PubMed ID: 31215423
[TBL] [Abstract][Full Text] [Related]
12. What are the biochemical parameters of pleural fluid that best identify parapneumonic effusions?
Santotoribio JD; León-Justel A; Delgado-Pecellín C; Guerrero JM
Ann Clin Biochem; 2009 Mar; 46(Pt 2):176-7. PubMed ID: 19151166
[No Abstract] [Full Text] [Related]
13. Pleural fluid lactate as a point-of-care adjunct diagnostic aid to distinguish tuberculous and complicated parapneumonic pleural effusions during initial thoracentesis: Potential use in a tuberculosis endemic setting.
Kho SS; Chan SK; Yong MC; Cheah HM; Lee YG; Tie ST
Respir Investig; 2020 Sep; 58(5):367-375. PubMed ID: 32107195
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of C-reactive protein in parapneumonic effusions.
Skouras V; Boultadakis E; Nikoulis D; Polychronopoulos V; Daniil Z; Kalomenidis I; Gourgoulianis KI
Respirology; 2012 Feb; 17(2):308-14. PubMed ID: 21995428
[TBL] [Abstract][Full Text] [Related]
15. Pleural fluid tests to identify complicated parapneumonic effusions.
Porcel JM
Curr Opin Pulm Med; 2010 Jul; 16(4):357-61. PubMed ID: 20224408
[TBL] [Abstract][Full Text] [Related]
16. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.
Heffner JE; Brown LK; Barbieri C; DeLeo JM
Am J Respir Crit Care Med; 1995 Jun; 151(6):1700-8. PubMed ID: 7767510
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
18. Parapneumonic effusions.
Light RW; Girard WM; Jenkinson SG; George RB
Am J Med; 1980 Oct; 69(4):507-12. PubMed ID: 7424940
[TBL] [Abstract][Full Text] [Related]
19. The differential diagnostic values of cytokine levels in pleural effusions.
Akarsu S; Kurt AN; Dogan Y; Yilmaz E; Godekmerdan A; Aygun AD
Mediators Inflamm; 2005 Feb; 2005(1):2-8. PubMed ID: 15770060
[TBL] [Abstract][Full Text] [Related]
20. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]